medazepam has been researched along with Chronic Disease in 2 studies
Medazepam: A benzodiazepine derivative used in the treatment of anxiety. It has sedative, muscle relaxant, and anticonvulsant properties. One of its metabolites is DIAZEPAM and one of its excretion products is OXAZEPAM.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bond, AJ | 2 |
| James, DC | 2 |
| Lader, MH | 2 |
2 trials available for medazepam and Chronic Disease
| Article | Year |
|---|---|
Sedative effects on physiological and psychological measures in anxious patients.
Topics: Amobarbital; Anti-Anxiety Agents; Anxiety; Auditory Perception; Chlordiazepoxide; Chronic Disease; C | 1974 |
Clinical comparison of anxiolytic drug therapy.
Topics: Administration, Oral; Adolescent; Adult; Amobarbital; Anti-Anxiety Agents; Anxiety; Barbiturates; Ca | 1974 |